Clene Inc. (CLNN) director receives 6,230 stock options at $4.19 strike

Rhea-AI Filing Summary

Clene Inc. director David J. Matlin received a grant of 6,230 stock options on August 13, 2026 under the Clene Inc. Amended 2020 Stock Plan. The options have an exercise price of $4.19 per share, vest immediately upon grant, and are exercisable into 6,230 shares of common stock until August 12, 2036. Following this award, Matlin holds 6,230 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MATLIN DAVID J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	stock option F1	6,230	$0.00	$0.00

Holdings After Transaction: stock option — 6,230 shares (Direct)

Footnotes (1)

1. F1. This option was granted on August 13, 2026 as an option for 6,230 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

Key Figures

Stock options granted: 6,230 options Exercise price: $4.19 per share Underlying shares: 6,230 shares +2 more

5 metrics

Stock options granted 6,230 options Grant to director David J. Matlin on August 13, 2026

Exercise price $4.19 per share Exercise price of options granted under Amended 2020 Stock Plan

Underlying shares 6,230 shares Common stock issuable upon exercise of granted options

Expiration date August 12, 2036 Expiry of options granted to David J. Matlin

Options held after transaction 6,230 options Total options directly held by David J. Matlin following grant

Key Terms

stock option, exercise price, vest immediately upon grant, Amended 2020 Stock Plan

4 terms

stock option financial

"This option was granted on August 13, 2026 as an option for 6,230 shares"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"at an exercise price of $4.19 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest immediately upon grant financial

"The options vest immediately upon grant"

Amended 2020 Stock Plan financial

"under the Clene Inc. Amended 2020 Stock Plan"

FAQ

What insider transaction did Clene Inc. (CLNN) report for David J. Matlin?

Clene Inc. reported that director David J. Matlin received a grant of 6,230 stock options on August 13, 2026. These options are exercisable into 6,230 shares of common stock under the company’s Amended 2020 Stock Plan.

What is the exercise price of the new Clene (CLNN) stock options granted to David J. Matlin?

The granted options carry an exercise price of $4.19 per share. Each option allows purchase of one share of Clene common stock at $4.19, regardless of future market price, until the options expire if not exercised.

When do David J. Matlin’s newly granted Clene (CLNN) stock options vest and expire?

The options vest immediately upon grant on August 13, 2026. They remain exercisable until their expiration date of August 12, 2036, giving a roughly 10-year window in which they may be exercised.

How many Clene (CLNN) stock options does David J. Matlin hold after this Form 4 transaction?

After the reported transaction, David J. Matlin holds 6,230 stock options directly. These options are all from the August 13, 2026 grant and are exercisable for 6,230 shares of Clene common stock at $4.19 per share.

Was the Clene (CLNN) option grant to David J. Matlin made under a specific equity plan?

Yes. The 6,230 stock options were granted under the Clene Inc. Amended 2020 Stock Plan. This plan governs the terms of the award, including the immediate vesting and the $4.19 per share exercise price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/14/2026 - 03:31 PM Accepted by SEC EDGAR 08/14/2026 - 03:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MATLIN DAVID J

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UTAH 84121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$4.19	08/13/2026		A		6,230		(1)	08/12/2036	common stock	6,230	$0	6,230	D

Explanation of Responses:

1. This option was granted on August 13, 2026 as an option for 6,230 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.19 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)